These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 10371700)
21. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats. Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654 [TBL] [Abstract][Full Text] [Related]
22. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1. Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291 [TBL] [Abstract][Full Text] [Related]
23. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization. Hata JA; Williams ML; Koch WJ J Mol Cell Cardiol; 2004 Jul; 37(1):11-21. PubMed ID: 15242731 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation. D'Souza KM; Petrashevskaya NN; Merrill WH; Akhter SA J Thorac Cardiovasc Surg; 2008 Jan; 135(1):172-9, 179.e1. PubMed ID: 18179937 [TBL] [Abstract][Full Text] [Related]
25. Multiple-site phosphorylation of the 280 kDa isoform of acetyl-CoA carboxylase in rat cardiac myocytes: evidence that cAMP-dependent protein kinase mediates effects of beta-adrenergic stimulation. Boone AN; Rodrigues B; Brownsey RW Biochem J; 1999 Jul; 341 ( Pt 2)(Pt 2):347-54. PubMed ID: 10393092 [TBL] [Abstract][Full Text] [Related]
26. Calcium antagonists, ventricular fibrillation, and enzyme release in ischemic rat hearts. Opie LH; Thandroyen FT Fed Proc; 1983 May; 42(8):2465-9. PubMed ID: 6132839 [TBL] [Abstract][Full Text] [Related]
27. Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. Iaccarino G; Lefkowitz RJ; Koch WJ Proc Assoc Am Physicians; 1999; 111(5):399-405. PubMed ID: 10519160 [TBL] [Abstract][Full Text] [Related]
28. Transgenic manipulation of beta-adrenergic receptor kinase modifies cardiac myocyte contraction to norepinephrine. Korzick DH; Xiao RP; Ziman BD; Koch WJ; Lefkowitz RJ; Lakatta EG Am J Physiol; 1997 Jan; 272(1 Pt 2):H590-6. PubMed ID: 9038983 [TBL] [Abstract][Full Text] [Related]
29. Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Jaber M; Koch WJ; Rockman H; Smith B; Bond RA; Sulik KK; Ross J; Lefkowitz RJ; Caron MG; Giros B Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12974-9. PubMed ID: 8917529 [TBL] [Abstract][Full Text] [Related]
30. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Koch WJ; Rockman HA; Samama P; Hamilton RA; Bond RA; Milano CA; Lefkowitz RJ Science; 1995 Jun; 268(5215):1350-3. PubMed ID: 7761854 [TBL] [Abstract][Full Text] [Related]
31. Differential G protein receptor kinase 2 expression in compensated hypertrophy and heart failure after myocardial infarction in the rat. Theilade J; Strøm C; Christiansen T; Haunsø S; Sheikh SP Basic Res Cardiol; 2003 Mar; 98(2):97-103. PubMed ID: 12607131 [TBL] [Abstract][Full Text] [Related]
32. Hope for a broken heart? Most P; Eicher C; Völkers M; Pleger ST; Katus HA Trends Biotechnol; 2004 Oct; 22(10):487-9. PubMed ID: 15450736 [TBL] [Abstract][Full Text] [Related]
33. Cardiac hypertrophy and altered beta-adrenergic signaling in transgenic mice that express the amino terminus of beta-ARK1. Keys JR; Greene EA; Cooper CJ; Naga Prasad SV; Rockman HA; Koch WJ Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2201-11. PubMed ID: 12869383 [TBL] [Abstract][Full Text] [Related]
34. Molecular beta-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Maurice JP; Shah AS; Kypson AP; Hata JA; White DC; Glower DD; Koch WJ Am J Physiol; 1999 Jun; 276(6):H1853-60. PubMed ID: 10362663 [TBL] [Abstract][Full Text] [Related]
35. Cardiac beta-adrenoceptor desensitization due to increased beta-adrenoceptor kinase activity in chronic uremia. Leineweber K; Heinroth-Hoffmann I; Pönicke K; Abraham G; Osten B; Brodde OE J Am Soc Nephrol; 2002 Jan; 13(1):117-124. PubMed ID: 11752028 [TBL] [Abstract][Full Text] [Related]
36. Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Iaccarino G; Barbato E; Cipolletta E; De Amicis V; Margulies KB; Leosco D; Trimarco B; Koch WJ Eur Heart J; 2005 Sep; 26(17):1752-8. PubMed ID: 16055494 [TBL] [Abstract][Full Text] [Related]
37. beta-adrenergic mechanisms in cardiac diseases: a perspective. Chakraborti S; Chakraborti T; Shaw G Cell Signal; 2000 Aug; 12(8):499-513. PubMed ID: 11027943 [TBL] [Abstract][Full Text] [Related]
38. Exploring the role of the beta-adrenergic receptor kinase in cardiac disease using gene-targeted mice. Koch WJ; Rockman HA Trends Cardiovasc Med; 1999; 9(3-4):77-81. PubMed ID: 10578521 [TBL] [Abstract][Full Text] [Related]
39. Unchanged G-protein-coupled receptor kinase activity in the aging human heart. Leineweber K; Klapproth S; Beilfuss A; Silber RE; Heusch G; Philipp T; Brodde OE J Am Coll Cardiol; 2003 Oct; 42(8):1487-92. PubMed ID: 14563597 [TBL] [Abstract][Full Text] [Related]
40. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Willerson JT Circulation; 1995 Aug; 92(3):277. PubMed ID: 7634434 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]